Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline
In This Article:
Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.